Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure and Preserved Ejection Fraction
Maura M. Zylla(Heidelberg University), Dierk Thomas(Heidelberg University), Norbert Frey(University Hospital Schleswig-Holstein), Ann‐Kathrin Rahm(Heidelberg University), Dorothea Kronsteiner(Zimmer Biomet (Netherlands)), Hugo A. Katus(Heidelberg University), Meinhard Kieser(Heidelberg University), Patrick Lugenbiel(Heidelberg University), Derliz Mereles(Heidelberg University), Patrick A. Schweizer(Goethe University Frankfurt), Tobias Hoffmann(Heidelberg University), Eberhard Scholz(Heidelberg University), Johannes Leiner(Heidelberg University)
Cited by 39
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k